AP
EW icon

Aspect Partners’s Edwards Lifesciences EW Stock Holding History

Aspect Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$995 Hold
11
– – ﹤0.01% 575
2026
Q1 		$881 Buy
11
+1
+10% +$82 ﹤0.01% 613
2025
Q4 		$853 Buy
+10
New +$821 ﹤0.01% 646
2024
Q2 		– Sell
-12
Closed -$1.15K – 576
2024
Q1 		$1.15K Hold
12
– – ﹤0.01% 482
2023
Q4 		$915 Buy
+12
New +$835 ﹤0.01% 477

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Aspect Partners's EW Position: Q2 2026 in Review

Aspect Partners held its Edwards Lifesciences (EW) position steady in Q2 2026 at 11 shares worth $995. The position accounts for ﹤0.01% of the portfolio, ranked #575.

Aspect Partners first reported a position in EW in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.15K in Q1 2024. 277 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Aspect Partners held 11 shares of Edwards Lifesciences worth $995 as of Q2 2026.
  • Aspect Partners left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #575 holding.
  • Aspect Partners first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 5 quarters since.
  • Aspect Partners's Edwards Lifesciences position peaked at $1.15K in Q1 2024.
  • 277 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.